• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CBER

FDA
Pharma

FDA's acting CDER head heads for the exit: report

A new departure shows that an intense period of FDA leadership turnover isn't over.
Eric Sagonowsky Jun 23, 2025 1:48pm
Cartoon of humanoid robot sitting at computer working
Favicon Fierce Biotech

FDA hopes AI can deliver 'rapid or instant' reviews

Jun 11, 2025 12:45pm
Robert F Kennedy Jr US President Donald Trumps nominee for Secretary of Health and Human Services testifies during hi
Favicon Fierce Biotech

At cell and gene roundtable, officials pledge to slash regulations

Jun 5, 2025 2:50pm
mysterious mystery person anonymous anonymous source whistleblower

Ex-CBER chief says FDA layoffs threaten future drug reviews: BMO

Apr 17, 2025 2:55pm
Marks

Former CBER head Peter Marks details forced exit from FDA: AP

Apr 8, 2025 5:20pm
Marks

FDA turmoil compounds challenges for cell and gene therapy field

Apr 2, 2025 3:16pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings